Caffeine/ephedrine promotes bodyweight loss.

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2002

Schlagwörter:	Obesity Caffeine Ephedrine Body Weight Loss Significant Adverse Effect

Anmerkung:	© Adis International Ltd 2002

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1349(2002), 1 vom: Aug., Seite 14-14
Übergeordnetes Werk:	volume:1349 ; year:2002 ; number:1 ; month:08 ; pages:14-14

Links:	Volltext

DOI / URN:	10.2165/00128413-200213490-00034

Katalog-ID:	SPR03513528X

Internformat


LEADER	01000caa a22002652 4500
001	SPR03513528X
003	DE-627
005	20230519203410.0
007	cr uuu---uuuuu
008	201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200213490-00034 \|2 doi
035			\|a (DE-627)SPR03513528X
035			\|a (SPR)00128413-200213490-00034-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Caffeine/ephedrine promotes bodyweight loss.
264		1	\|c 2002
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2002
650		4	\|a Obesity \|7 (dpeaa)DE-He213
650		4	\|a Caffeine \|7 (dpeaa)DE-He213
650		4	\|a Ephedrine \|7 (dpeaa)DE-He213
650		4	\|a Body Weight Loss \|7 (dpeaa)DE-He213
650		4	\|a Significant Adverse Effect \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1349(2002), 1 vom: Aug., Seite 14-14 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1349 \|g year:2002 \|g number:1 \|g month:08 \|g pages:14-14
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200213490-00034 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 1349 \|j 2002 \|e 1 \|c 08 \|h 14-14

Indexfelder

matchkey_str	article:22306056:2002----::afiepernpooeb
hierarchy_sort_str	2002
publishDate	2002
allfields	10.2165/00128413-200213490-00034 doi (DE-627)SPR03513528X (SPR)00128413-200213490-00034-e DE-627 ger DE-627 rakwb eng Caffeine/ephedrine promotes bodyweight loss. 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Obesity (dpeaa)DE-He213 Caffeine (dpeaa)DE-He213 Ephedrine (dpeaa)DE-He213 Body Weight Loss (dpeaa)DE-He213 Significant Adverse Effect (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1349(2002), 1 vom: Aug., Seite 14-14 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1349 year:2002 number:1 month:08 pages:14-14 https://dx.doi.org/10.2165/00128413-200213490-00034 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1349 2002 1 08 14-14
spelling	10.2165/00128413-200213490-00034 doi (DE-627)SPR03513528X (SPR)00128413-200213490-00034-e DE-627 ger DE-627 rakwb eng Caffeine/ephedrine promotes bodyweight loss. 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Obesity (dpeaa)DE-He213 Caffeine (dpeaa)DE-He213 Ephedrine (dpeaa)DE-He213 Body Weight Loss (dpeaa)DE-He213 Significant Adverse Effect (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1349(2002), 1 vom: Aug., Seite 14-14 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1349 year:2002 number:1 month:08 pages:14-14 https://dx.doi.org/10.2165/00128413-200213490-00034 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1349 2002 1 08 14-14
allfields_unstemmed	10.2165/00128413-200213490-00034 doi (DE-627)SPR03513528X (SPR)00128413-200213490-00034-e DE-627 ger DE-627 rakwb eng Caffeine/ephedrine promotes bodyweight loss. 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Obesity (dpeaa)DE-He213 Caffeine (dpeaa)DE-He213 Ephedrine (dpeaa)DE-He213 Body Weight Loss (dpeaa)DE-He213 Significant Adverse Effect (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1349(2002), 1 vom: Aug., Seite 14-14 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1349 year:2002 number:1 month:08 pages:14-14 https://dx.doi.org/10.2165/00128413-200213490-00034 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1349 2002 1 08 14-14
allfieldsGer	10.2165/00128413-200213490-00034 doi (DE-627)SPR03513528X (SPR)00128413-200213490-00034-e DE-627 ger DE-627 rakwb eng Caffeine/ephedrine promotes bodyweight loss. 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Obesity (dpeaa)DE-He213 Caffeine (dpeaa)DE-He213 Ephedrine (dpeaa)DE-He213 Body Weight Loss (dpeaa)DE-He213 Significant Adverse Effect (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1349(2002), 1 vom: Aug., Seite 14-14 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1349 year:2002 number:1 month:08 pages:14-14 https://dx.doi.org/10.2165/00128413-200213490-00034 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1349 2002 1 08 14-14
allfieldsSound	10.2165/00128413-200213490-00034 doi (DE-627)SPR03513528X (SPR)00128413-200213490-00034-e DE-627 ger DE-627 rakwb eng Caffeine/ephedrine promotes bodyweight loss. 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Obesity (dpeaa)DE-He213 Caffeine (dpeaa)DE-He213 Ephedrine (dpeaa)DE-He213 Body Weight Loss (dpeaa)DE-He213 Significant Adverse Effect (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1349(2002), 1 vom: Aug., Seite 14-14 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1349 year:2002 number:1 month:08 pages:14-14 https://dx.doi.org/10.2165/00128413-200213490-00034 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1349 2002 1 08 14-14
language	English
source	Enthalten in Inpharma weekly 1349(2002), 1 vom: Aug., Seite 14-14 volume:1349 year:2002 number:1 month:08 pages:14-14
sourceStr	Enthalten in Inpharma weekly 1349(2002), 1 vom: Aug., Seite 14-14 volume:1349 year:2002 number:1 month:08 pages:14-14
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Obesity Caffeine Ephedrine Body Weight Loss Significant Adverse Effect
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2002-08-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR03513528X
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR03513528X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519203410.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200213490-00034</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR03513528X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200213490-00034-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Caffeine/ephedrine promotes bodyweight loss.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2002</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2002</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Obesity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Caffeine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ephedrine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Body Weight Loss</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Significant Adverse Effect</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1349(2002), 1 vom: Aug., Seite 14-14</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1349</subfield><subfield code="g">year:2002</subfield><subfield code="g">number:1</subfield><subfield code="g">month:08</subfield><subfield code="g">pages:14-14</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200213490-00034</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1349</subfield><subfield code="j">2002</subfield><subfield code="e">1</subfield><subfield code="c">08</subfield><subfield code="h">14-14</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Caffeine/ephedrine promotes bodyweight loss Obesity (dpeaa)DE-He213 Caffeine (dpeaa)DE-He213 Ephedrine (dpeaa)DE-He213 Body Weight Loss (dpeaa)DE-He213 Significant Adverse Effect (dpeaa)DE-He213
topic	misc Obesity misc Caffeine misc Ephedrine misc Body Weight Loss misc Significant Adverse Effect
spellingShingle	misc Obesity misc Caffeine misc Ephedrine misc Body Weight Loss misc Significant Adverse Effect Caffeine/ephedrine promotes bodyweight loss.
topic_unstemmed	misc Obesity misc Caffeine misc Ephedrine misc Body Weight Loss misc Significant Adverse Effect
topic_browse	misc Obesity misc Caffeine misc Ephedrine misc Body Weight Loss misc Significant Adverse Effect
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Caffeine/ephedrine promotes bodyweight loss.
ctrlnum	(DE-627)SPR03513528X (SPR)00128413-200213490-00034-e
title_full	Caffeine/ephedrine promotes bodyweight loss
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2002
contenttype_str_mv	txt
container_start_page	14
container_volume	1349
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200213490-00034
title_sort	caffeine/ephedrine promotes bodyweight loss
title_auth	Caffeine/ephedrine promotes bodyweight loss.
abstract	© Adis International Ltd 2002
abstractGer	© Adis International Ltd 2002
abstract_unstemmed	© Adis International Ltd 2002
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Caffeine/ephedrine promotes bodyweight loss.
url	https://dx.doi.org/10.2165/00128413-200213490-00034
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200213490-00034
up_date	2024-07-03T13:43:04.211Z
_version_	1803565593224282112
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR03513528X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519203410.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200213490-00034</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR03513528X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200213490-00034-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Caffeine/ephedrine promotes bodyweight loss.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2002</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2002</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Obesity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Caffeine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ephedrine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Body Weight Loss</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Significant Adverse Effect</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1349(2002), 1 vom: Aug., Seite 14-14</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1349</subfield><subfield code="g">year:2002</subfield><subfield code="g">number:1</subfield><subfield code="g">month:08</subfield><subfield code="g">pages:14-14</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200213490-00034</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1349</subfield><subfield code="j">2002</subfield><subfield code="e">1</subfield><subfield code="c">08</subfield><subfield code="h">14-14</subfield></datafield></record></collection>
score	7.398695

Nicht das Richtige dabei?

Schreiben Sie uns!

Caffeine/ephedrine promotes bodyweight loss.

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?